News

Filter

Current filters:

None

Popular Filters

1 to 25 of 8849 results

Sanofi posts strong 2nd-qtr earnings, beating estimates

Sanofi posts strong 2nd-qtr earnings, beating estimates

31-07-2014

French pharma major Sanofi this morning reported that group sales for the second quarter of 2014 grew…

FinancialFranceGaucherGenzymeInsulin glargineMajorMiddle EastPharmaceuticalSanofi

Pfizer spends $635 million on acquiring two Baxter vaccines

Pfizer spends $635 million on acquiring two Baxter vaccines

30-07-2014

US pharma giant Pfizer has entered into a definitive agreement to acquire Baxter International portfolio…

Baxter InternationalMergers & AcquisitionsPfizerPharmaceuticalProductionUSAVaccines

Regeneron’s Eylea gains FDA approval for DME

Regeneron’s Eylea gains FDA approval for DME

30-07-2014

The Food and Drug Administration has approved US biotech firm Regeneron Pharmaceuticals’ Eylea (aflibercept)…

BayerBiotechnologyEyleaOphthalmicsRegeneronRegulationUSA

New indications approved in EU for Bristol-Myers/Pfizer Eliquis

New indications approved in EU for Bristol-Myers/Pfizer Eliquis

30-07-2014

The European Commission has approved US pharma majors Bristol-Myers Squibb and Pfizer’s Eliquis (apixaban)…

Bristol-Myers SquibbCardio-vascularEliquisEuropePfizerPharmaceuticalRegulation

Durata out-licenses dalbavancin to Angelini for certain territories

Durata out-licenses dalbavancin to Angelini for certain territories

30-07-2014

USA-based Durata Therapeutics says its Dutch subsidiary entered into a license and supply agreement with…

AngeliniAntibiotics and Infectious diseasesDalvanceDurata TherapeuticsEuropeLicensingPharmaceutical

Cellectis sells Swedish subsidiary to Japan’s Takara Bio

30-07-2014

France-based genome engineering specialist Cellectis says it has sold its Swedish subsidiary Cellectis…

BiotechnologyBusiness FinanceCellectisCellectis ABFranceMergers & AcquisitionsTakara Bio

Sanofi and Regneron say Phase III alirocumab trials met primary endpoint

Sanofi and Regneron say Phase III alirocumab trials met primary endpoint

30-07-2014

French drug major Sanofi and USA-based biotech firm Regeneron Pharmaceuticals have announced that nine…

alirocumabCardio-vascularGeorge YancopoulosPharmaceuticalResearchSanofiUSA

Bayer’s 2nd-qtr earnings hit by currency, missing expectations

Bayer’s 2nd-qtr earnings hit by currency, missing expectations

30-07-2014

Germany’s pharma and life sciences major Bayer posted a solid set of second-quarter 2014 financial…

BayerCancerConsumer HealthFinancialGermanyGermanyPharmaceuticalPulmonary hypertension

Ranbaxy down on same quarter last year following FDA fine

Ranbaxy down on same quarter last year following FDA fine

30-07-2014

Indian generic pharma company Ranbaxy, has reported consolidated sales of 23.7 billion rupees ($394 million),…

BSE SensexFinancialGenericsIndiaOver-the-counter accountingPharmaceutical industryRanbaxyRanbaxy Laboratories

AstraZeneca and Kyowa Hakko Kirin sign immunotherapy research deal

AstraZeneca and Kyowa Hakko Kirin sign immunotherapy research deal

30-07-2014

Anglo-Swedish pharma major AstraZeneca today announced that it has entered into a clinical study collaboration…

AstraZenecaBriggs MorrisonImmunologyJapanKyowa Hakko KirinOncologyPharmaceuticalResearchUK

FDA performs inspection of Impax's Taiwan facility

FDA performs inspection of Impax's Taiwan facility

30-07-2014

The US Food and Drug Administration has performed a general Good Manufacturing Practices (GMP) inspection…

Impax LaboratoriesNeurologicalPharmaceuticalRegulationRytaryUSA

Almirall's top-performing product in first half of 2014 is part of AstraZeneca selloff

Almirall's top-performing product in first half of 2014 is part of AstraZeneca selloff

30-07-2014

Spanish drug company Almirall has announced total revenues of 433.4 million euros ($508.8 million) for…

AlmirallEkliraEuroFinancialNabiximolsPharmaceuticalSpain

Amgen’s 2nd-qtr beats expectations, but firm slashes workforce

Amgen’s 2nd-qtr beats expectations, but firm slashes workforce

30-07-2014

Amgen, the largest global independent biotech firm, reported a 23% leap in second-quarter 2014 profit…

AmgenBiotechnologyFinancialManagement

AstraZeneca to acquire Almirall’s respiratory franchise, for up to $2.1 billion

AstraZeneca to acquire Almirall’s respiratory franchise, for up to $2.1 billion

30-07-2014

Anglo-Swedish pharma major AstraZeneca has entered an agreement to gain rights to the respiratory franchise…

AlmirallAstraZenecaEkliraMergers & AcquisitionsPharmaceuticalRespiratory and Pulmonary

Earnings at Pfizer tank but still just beat expectations

Earnings at Pfizer tank but still just beat expectations

29-07-2014

Taking the brunt of generic competition to former blockbuster drugs, US pharma giant Pfizer posted a…

FinancialPfizerPharmaceuticalUSA

Eli Lilly to establish production of insulin in Russia

Eli Lilly to establish production of insulin in Russia

29-07-2014

US pharma major Eli Lilly has reached an agreement with one of Russia’s leading drugmakers, R-Pharm,…

DiabetesEli LillyHumulin RInsulinPharmaceuticalProductionR-PharmRussia

Canada’s Health Minister moves on safe prescribing practices for drugs prone to abuse

Canada’s Health Minister moves on safe prescribing practices for drugs prone to abuse

29-07-2014

Canada’s Minister of Health, Rona Ambrose, has issued a national Call for Proposals to improve the…

CanadaNeurologicalPharmaceuticalRegulation

Recordati reports first half results with sales up 6.3%

Recordati reports first half results with sales up 6.3%

29-07-2014

Italian drugmaker Recordati saw its shares rise 2.1% to 12.30 euros after the company released first…

FinancialItalyPharmaceuticalRecordatiZanidip

1 to 25 of 8849 results

Back to top